Need a Health professional?

Shreyaansh Lifesciences, Jaipur. India

Tucatinib Tablets 150 mg
Tucatinib Tablets is used to treat adults with HER2-positive breast cancer that is advanced and cannot be removed by surgery or has spread to other parts of the body, including the brain.

Tucatinib, sold under the brand name Tukysa, is a small molecule inhibitor of HER2 for the treatment of HER2-positive breast cancer. Tucatinib was approved for medical use in the United States in April 2020, in Australia in August 2020, and in the European Union in February 2021.

Tucatinib tablets Available Price In India UK Saudi Arabia

Tucatinib Tablets

  • API – Tucatinib
  • Packaging – 60 tablets
  • Strength – 150 mg

What is Tucatinib Tablets used for?

  • Tucatinib Tablets used with trastuzumab and capecitabine to treat adults with HER2-positive breast cancer that is advanced and cannot be removed by surgery or has spread to other parts of the body, including the brain.

All Trademarks and Brands that appear on website belong to their respective owners and Ikris Pharma Network does not lay and claim on them we only provide Information. We are NOT ONLINE store and We do not sell Narcotics and Sedatives. Iron Sucrose is a pharmaceutical drug that legally requires a medical prescription to be dispensed. Following Information meant for Wholesalers, Suppliers, Exporters, Doctors, Comparator Supplies, Hospitals, Generic, Brand, Corporate Sourcing, reseller, and Pharmacies.

Get Access To Tucatinib Tablets 150 mg

Shreyaansh Lifesciences, Jaipur. India

Shreyaansh Lifesciences is registered in Jaipur, India. Registration Number : 08AEEFS9350K1ZI under GST Act. 
Branch Offices in India : Jaipur | New Delhi

SF-72-73 2ND FLOOR, Jaipur Electronic Market, Ridhi Sidhi Choraha, Jaipur, Rajasthan, 302018.

+91 99292 77766

Facts of Medicines

Tucatinib Tablets 150 mg


Tucatinib tablets should be stored at 20° to 25°C (68° to 77°F); excursions permitted to 15°to 30° C (59° to 86° F) [ Controlled Room Temperature]. Keep away from children.


Take this medicine by mouth with or without food as directed by your doctor, usually twice daily (about 12 hours apart). Swallow the medication whole. Do not chew, crush, or split the tablets. Do not take tablets if they are broken, cracked, or damaged.

If you miss a dose or vomit after taking tucatinib, do not take another dose. Take your next dose at the regular time.

Use this medication regularly to get the most benefit from it. To help you remember, take it at the same times each day.


Nausea, vomiting, mouth sores/pain, loss of appetite, weight loss, tiredness, or muscle/joint pain may occur. If any of these effects last or get worse, tell your doctor or pharmacist promptly.

Diarrhea is a common side effect and can sometimes be severe. Vomiting/diarrhea that doesn’t stop may result in dehydration. Contact your doctor promptly if you notice any symptoms of dehydration, such as unusual decreased urination, unusual dry mouth/thirst, fast heartbeat, or dizziness/lightheadedness. Your doctor may prescribe anti-diarrheal medication to take during treatment with this medication.


  • Before taking tucatinib, tell your doctor or pharmacist if you are allergic to it; or if you have any other allergies. This product may contain inactive ingredients, which can cause allergic reactions or other problems. Talk to your pharmacist for more details.

  • Before using this medication, tell your doctor or pharmacist your medical history, especially of: kidney disease, liver problems.

  •  Before having surgery, tell your doctor or dentist about all the products you use (including prescription drugs, nonprescription drugs, and herbal products).

  •  Since this drug can be absorbed through the skin and lungs and may harm an unborn baby, women who are pregnant or who may become pregnant should not handle this medication or breathe the dust from the tablets.

  •  Tell your doctor if you are pregnant or plan to become pregnant. Women of childbearing age should have a pregnancy test before starting treatment. You should not become pregnant while using tucatinib. Tucatinib may harm an unborn baby. Men with female partners of childbearing age should ask about reliable forms of birth control while using this medication and for at least 1 week after the last dose.

  • Women of childbearing age should ask about reliable forms of birth control while using this medication and for at least 1 week after the last dose. If you become pregnant, talk to your doctor right away about the risks and benefits of this medication. 

  • It is unknown if this medication passes into breast milk. Because of the possible risk to the infant, breast-feeding while using this drug and for at least 1 week after the last dose is not recommended. Consult your doctor before breast-feeding.

FAQs – Medicine Questions

Tucatinib Tablets 150 mg
What kind of drug is tucatinib?
Tucatinib is in a class of medications called kinase inhibitors. It works by blocking the action of the abnormal protein that signals cancer cells to multiply. This helps stop or slow the spread of cancer cells.
How is tucatinib administered?
The recommended tucatinib dose is 300 mg taken orally twice a day in combination with trastuzumab (at standard dosage) and capecitabine (1000 mg/m2 given orally twice daily on days 1-14 of a 21-day cycle) until disease progression or unacceptable toxicity.
How long can you take tucatinib?
Once the medication bottle is open, use tucatinib within 3 months. Throw away any medications remaining after this time if unused.
Where can I buy Tucatinib Tablets?

You can buy Tucatinib Tablets from any authorized whole-seller after getting a prescription from a qualified doctor. It is always better to check the credential of the whole-seller/supplier/exporter before buying the product.

The buyer should check the existing law in their home country before importing the product.

What is the procedure to buy Tucatinib Tablets?

Patients can simply fill the order form or can send mail at Patients can also send WhatsApp messages to +91 99292 77766 / 98738 10020   We will reply ASAP with the details of theTucatinib Tablets price as well as procurement procedure.

Note:- The order will be confirmed only after the receipt of the Valid prescription of the Clinician.

Who makes Tukysa?
The Food and Drug Administration said Tukysa, a twice-daily pill developed by Seattle Genetics, is for people with what’s known as HER2-positive breast cancer that has spread and resisted multiple other medicines.